Tomohiko Uchida

714 total citations
26 papers, 408 citations indexed

About

Tomohiko Uchida is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Tomohiko Uchida has authored 26 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 6 papers in Neurology. Recurrent topics in Tomohiko Uchida's work include Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (9 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Tomohiko Uchida is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (9 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Tomohiko Uchida collaborates with scholars based in Japan. Tomohiko Uchida's co-authors include Satoshi Kuwabara, Masahiro Mori, Akiyuki Uzawa, Hiroki Masuda, Ryohei Ohtani, Mayumi Muto, Saeko Masuda, Setsu Sawai, Shoichi Ito and Fumio Nomura and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Tomohiko Uchida

26 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiko Uchida Japan 13 289 181 93 90 79 26 408
Ryohei Ohtani Japan 12 230 0.8× 140 0.8× 68 0.7× 70 0.8× 75 0.9× 28 345
Mayumi Muto Japan 13 284 1.0× 195 1.1× 90 1.0× 80 0.9× 83 1.1× 24 441
Patrick Peschl Austria 7 324 1.1× 316 1.7× 74 0.8× 75 0.8× 80 1.0× 10 496
Saeko Masuda Japan 7 354 1.2× 238 1.3× 109 1.2× 138 1.5× 72 0.9× 11 442
Damiano Marastoni Italy 12 278 1.0× 124 0.7× 122 1.3× 95 1.1× 67 0.8× 35 433
Reinhard Reuß Germany 9 422 1.5× 337 1.9× 69 0.7× 73 0.8× 88 1.1× 14 573
Laura Bau Spain 11 315 1.1× 143 0.8× 37 0.4× 64 0.7× 64 0.8× 24 405
Elisabet Matas Spain 11 306 1.1× 128 0.7× 37 0.4× 64 0.7× 64 0.8× 23 419
Giordani Rodrigues dos Passos Brazil 9 262 0.9× 167 0.9× 45 0.5× 79 0.9× 56 0.7× 17 377
M. Starck Germany 8 298 1.0× 94 0.5× 97 1.0× 103 1.1× 72 0.9× 16 448

Countries citing papers authored by Tomohiko Uchida

Since Specialization
Citations

This map shows the geographic impact of Tomohiko Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiko Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiko Uchida more than expected).

Fields of papers citing papers by Tomohiko Uchida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiko Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiko Uchida. The network helps show where Tomohiko Uchida may publish in the future.

Co-authorship network of co-authors of Tomohiko Uchida

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiko Uchida. A scholar is included among the top collaborators of Tomohiko Uchida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiko Uchida. Tomohiko Uchida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2024). Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of Neurology Neurosurgery & Psychiatry. 95(7). 626–629. 4 indexed citations
2.
Uchida, Tomohiko, et al.. (2022). Posterior reversible encephalopathy syndrome (PRES) of the isolated brainstem. SHILAP Revista de lepidopterología. 10(4). e05712–e05712. 2 indexed citations
3.
Masuda, Hiroki, Masahiro Mori, Shigeki Hirano, et al.. (2021). Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Journal of Neurology Neurosurgery & Psychiatry. 93(1). 32–40. 25 indexed citations
4.
Takemura, Naoki, Masahiro Mori, Yoichi Suzuki, et al.. (2021). Cryptococcal Meningitis in a Fingolimod-Treated Patient. Neurology Clinical Practice. 11(4). e549–e550. 5 indexed citations
5.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2021). Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders. Journal of Neurology. 269(4). 1996–2003. 2 indexed citations
6.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2020). Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis. PLoS ONE. 15(4). e0224419–e0224419. 12 indexed citations
7.
Ohtani, Ryohei, Masahiro Mori, Tomohiko Uchida, et al.. (2018). Risk factors for fingolimod-induced lymphopenia in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(1). 2453179660–2453179660. 14 indexed citations
8.
Mori, Masahiro, Akiyuki Uzawa, Tomohiko Uchida, et al.. (2018). Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration. Journal of Neurology. 265(5). 1145–1150. 12 indexed citations
9.
Masuda, Hiroki, Masahiro Mori, Tomomi Furihata, et al.. (2018). Soluble CD40 ligand disrupts the blood–brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 316. 117–120. 13 indexed citations
10.
Masuda, Hiroki, Shigeki Hirano, Nobuyoshi Takahashi, et al.. (2017). Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS ONE. 12(8). e0184012–e0184012. 13 indexed citations
11.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2017). Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica. Clinica Chimica Acta. 469. 144–149. 34 indexed citations
12.
Masuda, Hiroki, Masahiro Mori, Tomohiko Uchida, et al.. (2017). Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 305. 102–107. 41 indexed citations
13.
Uchida, Tomohiko, Masahiro Mori, Akiyuki Uzawa, et al.. (2016). Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood–brain barrier disruption. Multiple Sclerosis Journal. 23(8). 1072–1084. 47 indexed citations
14.
Uchida, Tomohiko, et al.. (2015). Evaluation of the Safety and Efficacy of Kaempferia parviflora Extract（SIRTMAX(R)）in Human―A Randomized Double‒blind, Placebo‒controlled Crossover Clinical Study―. 43(7). 997–1005. 1 indexed citations
15.
Muto, Mayumi, Masahiro Mori, Takaki Hiwasa, et al.. (2015). Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. Journal of Neuroimmunology. 284. 30–36. 16 indexed citations
16.
Uzawa, Akiyuki, Masahiro Mori, Tomohiko Uchida, et al.. (2015). Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. Clinica Chimica Acta. 453. 131–133. 10 indexed citations
17.
Sugiyama, Atsuhiko, Masahiro Mori, Hiroki Masuda, et al.. (2015). Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis. Journal of the Neurological Sciences. 355(1-2). 147–149. 14 indexed citations
18.
Masuda, Saeko, Masahiro Mori, Kimihito Arai, et al.. (2014). Epstein-Barr virus persistence and reactivation in neuromyelitis optica. Journal of Neurology Neurosurgery & Psychiatry. 86(10). 1137–1142. 32 indexed citations
19.
Uzawa, Akiyuki, Masahiro Mori, Mayumi Muto, et al.. (2014). Benign neuromyelitis optica is rare in Japanese patients. Multiple Sclerosis Journal. 21(9). 1204–1208. 4 indexed citations
20.
Uzawa, Akiyuki, Masahiro Mori, Setsu Sawai, et al.. (2013). Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clinica Chimica Acta. 421. 181–183. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryohei Ohtani Breakdown of academic impact, for papers by Mayumi Muto Breakdown of academic impact, for papers by Patrick Peschl Breakdown of academic impact, for papers by Saeko Masuda Breakdown of academic impact, for papers by Damiano Marastoni Breakdown of academic impact, for papers by Reinhard Reuß Breakdown of academic impact, for papers by Laura Bau Breakdown of academic impact, for papers by Elisabet Matas Breakdown of academic impact, for papers by Giordani Rodrigues dos Passos Breakdown of academic impact, for papers by M. Starck
Rankless by CCL
2026